Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer

American Journal of Surgery

Volumn 199, Issue 5, 2010, Pages 657-662

  Clark, Clancy J ^a   Traverso, L William ^a  

^a Department of General Surgery ^*  (United States)

Author keywords

Carcinoma; Cytology; Laparoscopy; Minimally invasive; Pancreatic ductal; Peritoneal lavage; Surgical procedures

Indexed keywords

GEMCITABINE;

ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROSCOPY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS BIOPSY; PANCREAS CANCER; PERITONEAL FLUID; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; CAUSE OF DEATH; COHORT STUDIES; CYTODIAGNOSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951946258     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.01.021     Document Type: Article

References (21)

1. Ries LAG, Melbert D, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008.
2. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. National failure to operate on early stage pancreatic cancer. Ann Surg 246 (2007) 173-180
3. Riall T.S., and Lillemoe K.D. Underutilization of surgical resection in patients with localized pancreatic cancer. Ann Surg 246 (2007) 181-182
4. Katz M.H., Pisters P.W., Evans D.B., et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206 (2008) 833-846
5. Minnard E.A., Conlon K.C., Hoos A., et al. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg 228 (1998) 182-187
6. Makary M.A., Warshaw A.L., Centeno B.A., et al. Implications of peritoneal cytology for pancreatic cancer management. Arch Surg 133 (1998) 361-365
7. Conlon K.C., Dougherty E., Klimstra D.S., et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223 (1996) 134-140
8. Warshaw A.L., Tepper J.E., and Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 151 (1986) 76-80
9. Jimenez R.E., Warshaw A.L., and Fernandez-Del Castillo C. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreat Surg 7 (2000) 15-20
10. Warshaw A.L. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161 (1991) 26-29
11. Meszoely I.M., Lee J.S., Watson J.C., et al. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Am Surg 70 (2004) 208-213
12. Liu R.C., and Traverso L.W. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc 19 (2005) 638-642
13. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
14. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
15. White R., Winston C., Gonen M., et al. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 206 (2008) 445-450
16. Greene F.F., Page D.L., Fleming I.D., et al. AJCC staging handbook. 6th ed. (2002), Springer, New York
17. Yamada S., Takeda S., Fujii T., et al. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis. Ann Surg 246 (2007) 254-258
18. Ferrone C.R., Haas B., Tang L., et al. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg 10 (2006) 1347-1353
19. Connor S., Bosonnet L., Alexakis N., et al. Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy. Dig Surg 22 (2005) 80-85
20. Karachristos A., Scarmeas N., and Hoffman J.P. CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer. J Gastrointest Surg 9 (2005) 1286-1292
21. Ferrone C.R., Finkelstein D.M., Thayer S.P., et al. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 24 (2006) 2897-2902